Insufficient radiofrequency ablation therapy may induce further malignant transformation of hepatocellular carcinoma-Reference-Cited by-同舟云学术

Insufficient radiofrequency ablation therapy may induce further malignant transformation of hepatocellular carcinoma

Published:2008-01-29 Issue:1 Volume:2 Page:116-123
ISSN:1936-0533
Container-title:Hepatology International
language:en
Short-container-title:Hepatol Int

Author:

Obara Koichi,Matsumoto Nobuyuki,Okamoto Masaru,Kobayashi Minoru,Ikeda Hiroki,Takahashi Hideaki,Katakura Yoshiki,Matsunaga Kotaro,Ishii Toshiya,Okuse Chiaki,Suzuki Michihiro,Itoh Fumio

Publisher

Springer Science and Business Media LLC

Subject

Hepatology

Link

http://link.springer.com/content/pdf/10.1007/s12072-007-9040-3.pdf

Reference27 articles.

1. Befeler AS, Di Bisceglie AM. Hepatocellular carcinoma: diagnosis and treatment. Gastroenterology 2002;122:1609–19.

2. Buscarini L, Buscarini E. Therapy of HCC-radiofrequency ablation. Hepatogastroenterology 2001;48:15–9.

3. Livraghi T, Lazzaroni S, Meloni F. Radiofrequency thermal ablation of hepatocellular carcinoma. Eur J Ultrasound 2001;13:159–66.

4. Lopez PM, Villanueva A, Llovet JM. Systematic review: evidence-based management of hepatocellular carcinoma—an updated analysis of randomized controlled trials. Aliment Pharmacol Ther 2006;23:1535–47.

5. Marrero JA. Hepatocellular carcinoma. Curr Opin Gastroenterol 2006;22:248–53.

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sarcomatoid hepatocellular carcinoma: A case report and review of the literature;Medicine;2024-03-29

2. Sublethal thermal stress promotes migration and invasion of thyroid cancer cells;PLOS ONE;2024-02-23

3. Treatment and Prognostic Implications of Strong PD-L1 Expression in Primary Hepatic Sarcomatoid Carcinoma;Immunotherapy;2024-02-16

4. Spontaneous Tumor Lysis Syndrome in a Case of Hepatocellular Carcinoma with Sarcomatoid Differentiation;Indian Journal of Surgical Oncology;2024-02-13

5. Surgery after combination therapy with a tyrosine kinase inhibitor and anti-PD-1 antibody in sarcomatoid hepatocellular carcinoma: case report and literature review;Frontiers in Oncology;2023-10-05